193
Participants
Start Date
February 3, 2016
Primary Completion Date
October 2, 2017
Study Completion Date
December 21, 2017
peginterferon beta-1a
125 mcg administered subcutaneously (SC) every 2 weeks.
Research Site, Orbassano
Research Site, Torino
Research Site, Mondovì
Research Site, Genova
Research Site, Pietra Ligure
Research Site, Milan
Research Site, Milan
Research Site, Gallarate
Research Site, Como
Research Site, Pavia
Research Site, Modena
Research Site, Fidenza
Research Site, Arezzo
Research Site, Chieti
Research Site, L’Aquila
Research Site, Bari
research Site, Napoli
Research Site, Napoli
Research Site, Pozzilli
Research Site, Reggio Calabria
Research Site, Cefalù
Research Site, Palermo
Research Site, Palermo
Research Site, Messina
Research Site, Cagliari
Research Site, Foligno
Research Site, Ozieri
Research Site, Roma
Research Site, Roma
Research Site, Roma
Lead Sponsor
Biogen
INDUSTRY